RhumbLine Advisers Portfolio holdings
AUM
$117B
This Quarter Return
+0.65%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,360
Reduced
1,565
Closed
46
Top Buys
| 1 |
Moderna
MRNA
|
$63.3M |
| 2 |
Analog Devices
ADI
|
$46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$36.7M |
| 4 |
Match Group
MTCH
|
$29M |
| 5 |
Tesla
TSLA
|
$20.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
$86.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$77.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$76.7M |
| 4 |
Apple
AAPL
|
$74M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$67.8M |
Sector Composition
| 1 | Technology | 23.92% |
| 2 | Financials | 14.19% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Couchbase
BASE
$1.35B
| $208K | ﹤0.01% |
+6,697
| New | +$208K |
|
2902
Monte Rosa Therapeutics
GLUE
$302M
| $206K | ﹤0.01% |
+9,233
| New | +$206K |
|
|
DS
2903
DELISTED
Drive Shack Inc.
DS
| $206K | ﹤0.01% |
73,199
+2,514
| +4% | +$7.08K |
|
|
DZSI
2904
DELISTED
DZS Inc. Common Stock
DZSI
| $206K | ﹤0.01% |
16,809
+416
| +3% | +$5.1K |
|
2905
Mustang Bio
MBIO
$10.7M
| $205K | ﹤0.01% |
102
+3
| +3% | +$6.03K |
|
|
KG
2906
Kestrel Group, Ltd.
KG
$198M
| $205K | ﹤0.01% |
3,247
+10
| +0.3% | +$631 |
|
2907
Nathan's Famous
NATH
$420M
| $205K | ﹤0.01% |
3,348
+20
| +0.6% | +$1.23K |
|
2908
CorMedix
CRMD
$1.01B
| $202K | ﹤0.01% |
43,356
+317
| +0.7% | +$1.48K |
|
2909
Tonix Pharmaceuticals
TNXP
$236M
| $202K | ﹤0.01% |
1
| – | – |
|
2910
Novo Nordisk
NVO
$249B
| $201K | ﹤0.01% |
+4,180
| New | +$201K |
|
|
NMTR
2911
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $201K | ﹤0.01% |
7,724
+500
| +7% | +$13K |
|
2912
ARS Pharmaceuticals
SPRY
$1.08B
| $200K | ﹤0.01% |
20,013
+3,333
| +20% | +$33.3K |
|
|
TRVN
2913
DELISTED
Trevena, Inc.
TRVN
| $195K | ﹤0.01% |
253
+8
| +3% | +$6.17K |
|
2914
Fortress Biotech
FBIO
$89.3M
| $195K | ﹤0.01% |
4,041
+164
| +4% | +$7.91K |
|
2915
Full House Resorts
FLL
$129M
| $195K | ﹤0.01% |
18,336
+1,164
| +7% | +$12.4K |
|
|
AHT
2916
Ashford Hospitality Trust
AHT
$36.7M
| $194K | ﹤0.01% |
1,317
+159
| +14% | +$23.4K |
|
|
LENZ
2917
LENZ Therapeutics
LENZ
$1.12B
| $193K | ﹤0.01% |
+1,678
| New | +$193K |
|
|
ITI
2918
DELISTED
Iteris, Inc.
ITI
| $193K | ﹤0.01% |
36,467
+311
| +0.9% | +$1.65K |
|
|
TAST
2919
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $189K | ﹤0.01% |
51,509
+801
| +2% | +$2.94K |
|
2920
Wave Life Sciences
WVE
$1.21B
| $182K | ﹤0.01% |
37,050
+2,670
| +8% | +$13.1K |
|
2921
Dianthus Therapeutics
DNTH
$769M
| $180K | ﹤0.01% |
1,547
-127
| -8% | -$14.8K |
|
2922
Solid Biosciences
SLDB
$439M
| $178K | ﹤0.01% |
4,974
+112
| +2% | +$4.01K |
|
2923
Harvard Bioscience
HBIO
$20.9M
| $177K | ﹤0.01% |
25,307
+1,800
| +8% | +$12.6K |
|
|
CSLT
2924
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $177K | ﹤0.01% |
112,933
+3,480
| +3% | +$5.45K |
|
2925
Aterian
ATER
$9.68M
| $175K | ﹤0.01% |
1,346
+103
| +8% | +$13.4K |
|